Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S
Int J Mol Sci. 2025; 25(24.
PMID: 39769234
PMC: 11676902.
DOI: 10.3390/ijms252413468.
Ramli I, Cheriet T, Posadino A, Giordo R, Fenu G, Chukwuemeka Nwachukwu K
EXCLI J. 2025; 23:1397-1439.
PMID: 39764218
PMC: 11701300.
DOI: 10.17179/excli2024-7791.
Yasothkumar D, Ramani P, Jayaraman S, Ramalingam K, Tilakaratne W
Head Neck Pathol. 2024; 18(1):28.
PMID: 38536520
PMC: 10973321.
DOI: 10.1007/s12105-024-01627-4.
Konstantopoulos G, Leventakou D, Saltiel D, Zervoudi E, Logotheti E, Pettas S
Viruses. 2024; 16(1).
PMID: 38257813
PMC: 10819893.
DOI: 10.3390/v16010113.
Gupta S, Silveira D, Piedade G, Ostrowski M, Mombach J, Hashimoto R
Noncoding RNA Res. 2023; 9(1):185-193.
PMID: 38125755
PMC: 10730431.
DOI: 10.1016/j.ncrna.2023.10.008.
Profiling miRNAs in tear extracellular vesicles: a pilot study with implications for diagnosis of ocular diseases.
Torimura A, Kanei S, Shimizu Y, Baba T, Uotani R, Sasaki S
Jpn J Ophthalmol. 2023; 68(1):70-81.
PMID: 37947908
DOI: 10.1007/s10384-023-01028-0.
Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined model.
Heishima K, Sugito N, Abe C, Hirata A, Sakai H, Akao Y
Mol Ther Nucleic Acids. 2023; 33:960-982.
PMID: 37727442
PMC: 10505924.
DOI: 10.1016/j.omtn.2023.06.009.
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
Reed E, Jankowski S, Spinella A, Noonan V, Haddad R, Nomoto K
Transl Res. 2023; 260:46-60.
PMID: 37353110
PMC: 10527608.
DOI: 10.1016/j.trsl.2023.05.007.
Orchestration of miRNA Patterns by Testosterone and Dietary Tomato Carotenoids during Early Prostate Carcinogenesis in TRAMP Mice.
Wan L, Thomas-Ahner J, Pearl D, Erdman Jr J, Moran N, Clinton S
J Nutr. 2023; 153(7):1877-1888.
PMID: 37187350
PMC: 10375503.
DOI: 10.1016/j.tjnut.2023.05.015.
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets.
You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S
Signal Transduct Target Ther. 2023; 8(1):196.
PMID: 37164974
PMC: 10172373.
DOI: 10.1038/s41392-023-01442-3.
LINC01296 promotes cancer stemness traits in oral carcinomas by sponging miR-143.
Liang K, Ho D, Yang H, Hsieh P, Fang C, Tsai L
J Dent Sci. 2023; 18(2):814-821.
PMID: 37021272
PMC: 10068493.
DOI: 10.1016/j.jds.2023.01.008.
Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer.
Kumari P, Sharma I, Saha S, Srinivasan R, Bhardwaj P
Indian J Med Res. 2023; 156(3):516-523.
PMID: 36751747
PMC: 10101355.
DOI: 10.4103/ijmr.IJMR_288_20.
Epigenetic regulation of core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome.
Pilala K, Papadimitriou M, Panoutsopoulou K, Barbarigos P, Levis P, Kotronopoulos G
Mol Ther Nucleic Acids. 2022; 30:311-322.
PMID: 36320325
PMC: 9614648.
DOI: 10.1016/j.omtn.2022.10.001.
The Methylation of the p53 Targets the Genes , , and in the Tumor Tissue of Diffuse Large B-Cell Lymphoma.
Voropaeva E, Pospelova T, Orlov Y, Churkina M, Berezina O, Gurazheva A
Genes (Basel). 2022; 13(8).
PMID: 36011313
PMC: 9408007.
DOI: 10.3390/genes13081401.
The Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses.
Capaccia C, Diverio S, Zampini D, Guelfi G
Cells. 2022; 11(10).
PMID: 35626668
PMC: 9139524.
DOI: 10.3390/cells11101631.
Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.
Jia Y, Li J, Wang J, Luo T, Jing X, Zhao H
Anal Cell Pathol (Amst). 2022; 2022:1732365.
PMID: 35602576
PMC: 9122712.
DOI: 10.1155/2022/1732365.
Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies.
Diez-Fraile A, De Ceulaer J, Derpoorter C, Spaas C, De Backer T, Lamoral P
Int J Mol Sci. 2022; 23(5).
PMID: 35269544
PMC: 8910330.
DOI: 10.3390/ijms23052403.
microRNA-Mediated Encoding and Decoding of Time-Dependent Signals in Tumorigenesis.
Tealdi S, Ferro E, Campa C, Bosia C
Biomolecules. 2022; 12(2).
PMID: 35204714
PMC: 8961662.
DOI: 10.3390/biom12020213.
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies.
Vahabi M, Blandino G, Di Agostino S
Transl Cancer Res. 2022; 10(6):3090-3110.
PMID: 35116619
PMC: 8797920.
DOI: 10.21037/tcr-20-2530.
Rhinoceros Serum microRNAs: Identification, Characterization, and Evaluation of Potential Iron Overload Biomarkers.
Wojtusik J, Curry E, Roth T
Front Vet Sci. 2022; 8:711576.
PMID: 34977204
PMC: 8716540.
DOI: 10.3389/fvets.2021.711576.